INTERLEUKIN-2 MEDIATES STIMULATION OF COMPLEMENT-C3 BIOSYNTHESIS IN HUMAN PROXIMAL TUBULAR EPITHELIAL-CELLS

被引:194
作者
BROOIMANS, RA
STEGMANN, APA
VANDORP, WT
VANDERARK, AAJ
VANDERWOUDE, FJ
VANES, LA
DAHA, MR
机构
[1] Department of Nephrology, University Hospital, Leiden
[2] Department of Nephrology, Building 1, C3-P, University Hospital, 2333 AA Leiden
关键词
COMPLEMENT SYNTHESIS; KIDNEY; LYMPHOKINES;
D O I
10.1172/JCI115314
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Previous reports have suggested the production of complement components C4, C2, and factor B by renal tissue. However, the cells involved in production of complement have not been identified. In this study metabolic labeling experiments demonstrated that human proximal tubular epithelial cells (PTEC) synthesize a 180-kD precursor of C3 that is secreted after proteolytic cleavage into a disulphide linked two-chain molecule as found in plasma. C3 present in culture supernatants of PTEC was functionally active, however, during the culture period there was a partial inactivation of the C3 molecule as assessed by hemolytic titration. Recombinant IL-2 enhances the rate of C3 synthesis in a dose-dependent manner reaching maximal stimulation at doses of 200-400 U/ml IL-2. Northern blot analysis demonstrated a 5.2-kb C3 mRNA species present in PTEC that was increased within 24 h of IL-2 treatment. IL-2-induced enhancement of C3 production by PTEC could be neutralized with specific antibodies to IL-2. This study demonstrates that C3 synthesis in PTEC is upregulated by IL-2, the major cytokine produced by activated T cells.
引用
收藏
页码:379 / 384
页数:6
相关论文
共 36 条
[1]   HUMAN C'3 - EVIDENCE FOR LIVER AS PRIMARY SITE OF SYNTHESIS [J].
ALPER, CA ;
JOHNSON, AM ;
BIRTCH, AG ;
MOORE, FD .
SCIENCE, 1969, 163 (3864) :286-&
[2]   PHASE-I EVALUATION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED MALIGNANT DISEASE [J].
ATKINS, MB ;
GOULD, JA ;
ALLEGRETTA, M ;
LI, JJ ;
DEMPSEY, RA ;
RUDDERS, RA ;
PARKINSON, DR ;
REICHLIN, S ;
MIER, JW .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (09) :1380-1391
[3]   BIOSYNTHESIS OF COMPLEMENT BY HUMAN-MONOCYTES [J].
BEATTY, DW ;
DAVIS, AE ;
COLE, FS ;
EINSTEIN, LP ;
COLTEN, HR .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1981, 18 (03) :334-343
[4]  
BORSOS T, 1961, J IMMUNOL, V87, P310
[5]  
BROOIMANS RA, 1989, J IMMUNOL, V142, P2024
[6]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[7]  
COLE FS, 1985, J IMMUNOL, V134, P2610
[8]   TISSUE-CULTURE OF HUMAN-KIDNEY EPITHELIAL-CELLS OF PROXIMAL TUBULE ORIGIN [J].
DETRISAC, CJ ;
SENS, MA ;
GARVIN, AJ ;
SPICER, SS ;
SENS, DA .
KIDNEY INTERNATIONAL, 1984, 25 (02) :383-390
[9]   EXPRESSION AND ROLE OF P75 INTERLEUKIN-2 RECEPTOR ON HUMAN MONOCYTES [J].
ESPINOZADELGADO, I ;
ORTALDO, JR ;
WINKLERPICKETT, R ;
SUGAMURA, K ;
VARESIO, L ;
LONGO, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1821-1826
[10]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13